April 6-7, 2006 - BioLink was proud to host its Fourth Annual Conference and Gala Awards Ceremony held in New York City.

The BioLink Conference included a series of three events, including an opening night reception, conference and Life Sciences Gala Awards dinner.  Mr. Dennis Purcess, Senior Managing Director of Aisling Captial, delivered the keynote address at the opening night reception on April 6th, with an official opening from The Honorable Tim O'Connor, the Consul General of Ireland.  The title of this year's conference was Metabolic Diseases - The Impact of Prosperity and was held on Friday, April 7th at Essex House, 160 Central Park South in New York City.

The event was considered very successful and enjoyable.  We look forward to bringing you details of the upcoming 2007 conference in the near future.

Three topics of interest were covered and these included:
(1) Cardiovascular Diseases: Current research, therapeutics and devices used in cardiovascular disease were discussed and this session was moderated by Dr. Donald Black, Head of Global R&D at GE Healthcare.  Speakers included:
Prof. Garret A. Fitzgerald, M.D., Professor of Medicine and Elmer Bobst Professor of Pharmacology, University of Pennsylvania
Dr. Euan MacIntyre, V.P. Drug Discovery, Merck & Co., Inc.
Dr. James Barry, V.P., Corporate Research & Advanced Technology Development, Boston Scientific
Prof. Luke Clancy, Director, General Research Institute for a Tobacco-Free Society, Dublin

(2) Diabetes: Current research, therapeutics and devices used in diabetes were discussed and this session was moderated by Dr. Steve Meller, Head of Global BioScience Business Development, Procter and Gamble.  Speakers included:
Prof. Stephen O'Rahilly, Professor of Clinical Biochemistry and Medicine, Cambridge University, England
Dr. Joseph O'Sullivan, Senior Director, Research, Bristol Myers Squibb (Retired)
Dr. Alan Krasner, Director, Metabolic Diseases, Pfizer Global Research & Development

(3) Lifescience Links with Ireland: Opportunities and potential for collaboration and R&D partnerships in Ireland were presented and discussed and the session was moderated by Dr. Hugh Brady, MD, PhD, President of University College Dublin.  Speakers included:
Dr. Paul Roben, Bio Commercialization, Enterprise Ireland
Mr. Barry O'Dowd, SVP, Pharmaceutical and Biotechnology, IDA
Mr. Liam Nellis, Chief Executive, InterTradeIreland
Mr. James O'Neill, Senior Advisor to the Deputy Secretary, Dept of Health & Human Services

The BioLink USA-Ireland Black Tie Life Science Gala Awards Ceremony at Essex House, 160 Central Park South held on the Friday night honored the following individuals:
Dr. Hugh Brady, MD, PhD, President of University College Dublin
Ms. Elaine Brennan, Senior Vice President of Operations at Montefiore Medical Center, New York
Mr. Peter R. Dolan, Chief Executive Officer, Bristol Myers Squibb
Dr. Marie Filbin, City University of New York, Distinguished Professor and Director of the Specialized Neuroscience Research Program, Hunter College, CUNY
Dr. Terence Lambe, Vice President and Area Team Leader, Ireland/Singapore, Pfizer Global Manufacturing
Dr. Stephen O'Rahilly, Professor of Clinical Biochemistry and Medicine, Cambridge University, England
Mr. Thomas E. O'Toole, Deputy Director and Chief Licensing Officer of Centers for Disease Control's Technology Transfer Office
Mr. Dennis Purcell, Senior Managing Director, Aisling Capital LLC
Mr. James H. Taylor, Jr., Boston Scientific, Inc., former Executive Vice President, Corporate Operations
Dr. Frank Walsh, Executive VP, Discovery Research Worldwide for Wyeth